Croda International (LON:CRDA) Hits New 52-Week Low Following Insider Selling

Croda International Plc (LON:CRDA - Get Free Report) shares reached a new 52-week low during trading on Tuesday following insider selling activity. The company traded as low as GBX 2,567 ($33.60) and last traded at GBX 2,613.63 ($34.21), with a volume of 800317 shares traded. The stock had previously closed at GBX 2,754 ($36.05).

Specifically, insider Tom Brophy sold 380 shares of the company's stock in a transaction on Monday, April 7th. The shares were sold at an average price of GBX 2,643 ($34.59), for a total transaction of £10,043.40 ($13,145.81).

Croda International Stock Up 0.3 %

The company has a market capitalization of £3.68 billion, a P/E ratio of 22.62, a PEG ratio of 1.40 and a beta of 0.74. The company has a debt-to-equity ratio of 30.90, a current ratio of 2.72 and a quick ratio of 2.25. The company has a 50 day moving average of GBX 3,035.46 and a 200-day moving average of GBX 3,383.86.

Croda International (LON:CRDA - Get Free Report) last issued its quarterly earnings data on Tuesday, February 25th. The company reported GBX 142.60 ($1.87) earnings per share for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. As a group, equities analysts anticipate that Croda International Plc will post 181.8307268 EPS for the current year.

Croda International Increases Dividend

The business also recently disclosed a dividend, which will be paid on Wednesday, May 28th. Shareholders of record on Thursday, April 10th will be issued a GBX 63 ($0.82) dividend. The ex-dividend date is Thursday, April 10th. This is a positive change from Croda International's previous dividend of $47.00. This represents a yield of 2.03%. Croda International's dividend payout ratio is 93.66%.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.